Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 6/2006

01-11-2006

The Impact of Syringe Deregulation on Sources of Syringes for Injection Drug Users: Preliminary Findings

Authors: Sherry Deren, Charles M. Cleland, Crystal Fuller, Sung-Yeon Kang, Don C. Des Jarlais, David Vlahov

Published in: AIDS and Behavior | Issue 6/2006

Login to get access

Abstract

In 2001, New York State enacted legislation to allow the provision of syringes by pharmacies and healthcare providers without prescription (ESAP, the Expanded Syringe Access Demonstration Program). A longitudinal study of IDUs (n=130) found that pre-ESAP, about half used only the safest source (needle exchange programs [NEPs]). Post-ESAP implementation, ESAP sources were initiated by 14%. Frequency of injection was related to ESAP use and those who used unsafe (or possibly unsafe) sources were as likely to use ESAP as those who had previously used only NEPs. The findings indicate that providing multiple sources of safe syringes for IDUs is necessary.
Literature
Carneiro, M., Fuller, C., Doherty, M., and Vlahov, D. (1999). HIV prevalence and risk behaviors among new initiates into injection drug use over the age of 40 years old. Drug and Alcohol Dependence, 54, 83–86.PubMedCrossRef
Center for Urban Epidemiologic Studies, New York Academy of Medicine, Beth Israel Medical Center, and National Development and Research Institutes, Inc. (2003). New York State Expanded Syringe Access Demonstration Program Evaluation. New York: New York Academy of Medicine.
Colón, H. M., Robles, R. R., Deren, S., Sahai, H., Finlingon, H., Andia, J., et al. (2003). Between-city variation in frequency of injection among Puerto Rican injection drug users: East Harlem, New York and Bayamon, Puerto Rico. Journal of Psychoactive Drugs, 35, 197–207.PubMed
Deren, S., Fuller, C., Pouget, E. R., Blaney, S., Tortu, S., Kang, S. Y., et al. (2003). Impact of expanding syringe access in New York on sources of syringes for injection drug users in Harlem and the Bronx, NYC, USA. International Journal of Drug Policy, 14, 373–379.CrossRef
Deren, S., Oliver-Velez, D., Finlinson, A., Robles, R. R., Andia, J., Colón, H. M., et al. (2003). Integrating qualitative and quantitative methods: comparing HIV-related risk behaviors among Puerto Rican drug users in Puerto Rico and New York. Substance Use and Misuse, 38, 1–24.PubMedCrossRef
Des Jarlais, D. C., Marmor, M., Friedmann, P., Titus, S., Aviles, E., Deren, S., et al. (2000). HIV incidence among injection drug users in New York City, 1992–1997: evidence for a declining epidemic. American Journal of Public Health, 90, 352–359.PubMedCrossRef
Des Jarlais, D. C., McKnight, C., and Friedmann, P. (2002). Legal syringe purchases by injection drug users, Brooklyn and Queens, New York City, 2000–2001. Journal of the American Pharmaceutical Association, 42 (Suppl. 2), S73–S76.PubMed
Fuller, C., Galea, S., Blaney, S., Ompad, D. C., Deren, S., Des Jarlais, D. C., et al. (2004). Explaining the relationship between race/ethnicity and pharmacy purchased syringes among injection drug users in New York City. Ethnicity and Disease, 14, 589–596.PubMed
Hagan, H., Thiede, H., and Des Jarlais, D. C. (2004). Hepatitis C virus infection among injection drug users: survival analysis of time to seroconversion. Epidemiology, 15, 543–549.PubMedCrossRef
Klein, S. J., Estel, G. R., Candelas, A. R., and Plavin, H. A. (2002). Promoting safe syringe disposal goes “hand in hand” with Expanded Syringe Access in New York State. Journal of the American Pharmaceutical Association, 42 (Suppl. 2), S29–S31.PubMed
Normand, J., Vlahov, D., and Moses, L. E. (eds.). (1995). Preventing HIV transmission: the role of sterile needles and bleach. Washington, DC: National Academy of Medicine.
Pouget, E. R., Deren, S., Fuller, C., Blaney, S., McMahon, J., Kang, S. Y., et al. (2005). Receptive syringe sharing among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program. Journal of Acquired Immune Deficiency Syndromes, 39, 471–477.PubMedCrossRef
Metadata
Title
The Impact of Syringe Deregulation on Sources of Syringes for Injection Drug Users: Preliminary Findings
Authors
Sherry Deren
Charles M. Cleland
Crystal Fuller
Sung-Yeon Kang
Don C. Des Jarlais
David Vlahov
Publication date
01-11-2006
Published in
AIDS and Behavior / Issue 6/2006
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-006-9096-4

Other articles of this Issue 6/2006

AIDS and Behavior 6/2006 Go to the issue

Original Paper

Improving Dietary Habits in Disadvantaged Women With HIV/AIDS: The SMART/EST Women's Project

Original Paper

Examining the role of partner status in an HIV prevention trial targeting HIV-positive gay and bisexual men: the seropositive urban men’s intervention trial (SUMIT)

Original Paper

A Controlled Study of an HIV/AIDS/STI/TB Intervention with Traditional Healers in KwaZulu-Natal, South Africa

Original Article

Providers’ HIV Prevention Discussions with HIV-Seropositive Injection Drug Users

Original Paper

I Can Use a Condom, I Just Don’t: The Importance of Motivation to Prevent HIV in Adolescent Seeking Psychiatric Care

Original Article

Assessing the Efficacy of a Voluntary HIV Counseling and Testing Intervention for Pregnant Women and Male Partners in Urumqi City, China
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits